Cn /En

News Center

——

Company news

Industry news

InnoModels Biotechnology: What are the features of the iHuPBMC-OncVax platform?

Author:

InnoModels

Release time:

2024-06-05

In today's era of continuous integration of biotechnology and medical field, personalized medicine has gradually become the focus of people's attention. With its profound accumulation in the field of biotechnology and immunotherapy, InnoModels Biotechnology has successfully developed the iHuPBMC-OncVax platform, which, with its unique features and advantages, brings unprecedented possibilities for tumor immunotherapy.
The iHuPBMC-OncVax platform is a key sub-platform of the next-generation PBMC immune system humanization model launched by InnoModels Biotechnology. Its core feature is the ability to fully simulate the response process of the human immune system and provide an evaluation tool for tumor vaccines and other immunotherapies that require antigen presentation. This platform not only realizes the comprehensive reconstruction of human immune cells, but also transcends the limitations of the traditional PBMC model and truly realizes the full humanization of the immune system.
The biggest highlight of this platform is its ability to simulate personalized immune responses. Traditional immunotherapy methods often lack consideration of individual immune characteristics, leading to uneven treatment results. The iHuPBMC-OncVax platform, on the other hand, enables vaccines or immunotherapies to more accurately reflect individual patient's immune characteristics by using the patient's own peripheral blood mononuclear cells (PBMCs). This personalized design makes immunotherapy more precise and greatly improves therapeutic efficacy.

In addition, the iHuPBMC-OncVax platform is able to comprehensively simulate the tumor microenvironment, including the interactions between immune cells, tumor cells, and cytokines. This simulation not only helps to deeply study the tumor immune escape mechanism, but also provides strong support for the development of novel therapeutic strategies. Researchers can use this platform to conduct in-depth studies on various aspects of tumor immunotherapy, so as to find more effective therapeutic methods.
It is worth mentioning that the iHuPBMC-OncVax platform also has a wide range of application prospects. It can be used not only for the development and evaluation of tumor vaccines, but also for the evaluation of immune checkpoint inhibitors, immunomodulators, and many other immunotherapy strategies. This means that the platform not only provides strong support for the field of tumor immunotherapy, but also provides new research tools for other immunotherapy fields.
In summary, with its personalized immune response simulation, comprehensive tumor microenvironment simulation, and wide application prospects, the iHuPBMC-OncVax platform of InnoModels Biotechnology has brought a brand-new breakthrough to the field of tumor immunotherapy. With the deepening of the platform's research and clinical application, it is believed that more patients will benefit from it in the future and enjoy more accurate and effective personalized tumor immunotherapy services.

InnoModels Biotechnology: What are the features of the CDX platform?

InnoModels Biotechnology: What are the features of the iHuPBMC-B platform?

InnoModels Biotechnology: What are the features of the CDX platform?

InnoModels Biotechnology: What are the features of the iHuPBMC-B platform?

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License